Original Source(s)
Related Content
Oral Shigella Vaccine Hits 89% Efficacy in Challenge Trial
An investigational oral Shigella sonnei vaccine showed robust protection against shigellosis in a phase 2 controlled human infection trial.
by Teraya Smith
July 23, 2026
-
3 min
Bringing it Home: Why We Switched to In-House WGS
Annette Kim shares her experience of a real-world clinical laboratory transition to whole-genome sequencing
July 24, 2026
-
8 min
Weekly HIV Therapy Meets Primary Endpoint
Patients who switched from daily antiretroviral therapy maintained virologic suppression in two phase 3 trials.
July 23, 2026
-
3 min